»ó´Ü¿©¹é
±â»ç (Àüü 407°Ç)
[Interview] ¡°½ºÅ¸Æ¾ ´Üµ¶¿ä¹ý ÀÌ»óÁöÁúÇ÷Áõ °ü¸®ÀÇ ½ÃÀÛ¡± ÀÓ¼¼Çü ±âÀÚ 2023-05-04 16:45
[Sub Story] LDL-C ¸ñǥġ ÇÏÇâ°ú ½ºÅ¸Æ¾·ºñ½ºÅ¸Æ¾°è º´¿ëÀÇ »ó°ü°ü°è ÀÌ»óµ· ±âÀÚ 2023-05-04 16:31
[Interview] ¡°ÀþÀº ¼ºÀκÎÅÍ Àû±ØÀûÀ¸·Î LDL-C °ü¸®Çؾߡ± ÀÓ¼¼Çü ±âÀÚ 2023-05-04 16:24
[Late Breaking Studies] ½ºÅ¸Æ¾ vs ½ºÅ¸Æ¾ + ¿¡Á¦Æ¼¹Ìºê ±Ù°Å¿Í ÇöÁÖ¼Ò Â¤¾îº¸±â ÀÓ¼¼Çü ±âÀÚ 2023-05-04 16:11
[Sub Story] ACS ȯÀÚ ÀÌ»óÁöÁúÇ÷Áõ ÃʱâÄ¡·á 2¡¤3Á¦ º´¿ëÀ¸·Î? ÀÌ»óµ· ±âÀÚ 2023-05-04 15:29
¶óÀÎ
[Interview] LDL-C Ä¡·á Æз¯´ÙÀÓ, The Lower¡¤The Earlier ÀÌ»óµ· ±âÀÚ 2023-05-04 14:32
[Sub Story] Çѱ¹ÀÎ °íÁß¼ºÁö¹æÇ÷Áõ Ä¡·á¿¡ ÇǺ극ÀÌÆ®¡¤¿À¸Þ°¡-3Áö¹æ»ê ÀÌ»óµ· ±âÀÚ 2023-05-04 14:24
[Deep in Guideline] ±¹³» °íÇ÷¾Ð ¸ÂÃãÄ¡·á, Ç÷¾ÐºÐ·ùºÎÅÍ ½ÃÀÛ ÀÓ¼¼Çü ±âÀÚ 2023-05-04 14:20
[Conference Report] ReDM BUSAN 2023 SYMPOSIUM ÀÓ¼¼Çü ±âÀÚ 2023-05-04 10:43
[Sub Story] Ç÷¾Ð¡¤ÁöÁú µ¿½ÃÁ¶Àý·Î ½ÉÇ÷°üÁúȯ 1¡¤2Â÷¿¹¹æ ´Þ¼º ÀÌ»óµ· ±âÀÚ 2023-04-03 15:48
¶óÀÎ
[Sub Story] ´ç´¢º´¡¤ÀÌ»óÁöÁúÇ÷Áõ µ¿¹ÝÀÌȯÀÇ º´Å»ý¸® ÀÌ»óµ· ±âÀÚ 2023-04-03 15:34
[Cover Story] LDL-C ¸ñǥġ º¯Ãµ»ç 100 ¡æ 70 ¡æ 55mg/dL ÀÌ»óµ· ±âÀÚ 2023-03-10 18:38
[Sub Story] ¡°ÃÊ°íÀ§Ç豺 LDL-C ¸ñǥġ ÇÏÇâ±¹¸é ¶Ñ·Ç¡± ÀÌ»óµ· ±âÀÚ 2023-03-10 18:33
[Sub Story] ½ºÅ¸Æ¾°ú ÇÔ²² ÇÑ LDL-C ¸ñǥġ º¯Ãµ»ç ÀÌ»óµ· ±âÀÚ 2023-03-10 18:04
[Interview] ´ç´¢º´ µ¿¹Ý ASCVD, °í¿ë·® ½ºÅ¸Æ¾º¸´Ù
Áß°­µµ ½ºÅ¸Æ¾ + ¿¡Á¦Æ¼¹Ìºê º´¿ëÀÌ ´õ È¿°úÀû
ÀÌ»óµ· ±âÀÚ 2023-03-10 17:57
¶óÀÎ
[Sub Story] IMPROVE-IT, ºñ½ºÅ¸Æ¾°è ¹«¿ë·Ð ÀáÀç¿ö ÀÌ»óµ· ±âÀÚ 2023-03-10 17:48
[Interview] Áö³­ 10³â ¡®½ºÅ¸Æ¾°ú ´ç´¢º´ À§Ç衯 ´ã·Ð
ÇâÈÄ 10³â ½ºÅ¸Æ¾/ºñ½ºÅ¸Æ¾°è·Î
ÀÌ»óµ· ±âÀÚ 2023-03-10 16:19
[Interview] ±¹³» ÃÖÃÊ SGLT-2¾ïÁ¦Á¦ À̳ªº¸±Û¸®Ç÷ÎÁø THE MOST 2023-03-10 15:53
[Conference Report] ÇãÇ÷¼º ³úÁ¹Áß¿¡ ´ëÇÑ NOAC È¿°ú È®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2023-03-10 13:45
[Conference Report] 1ÀÏ 2ȸ DPP-4¾ïÁ¦Á¦ ½ÄÈÄÇ÷´ç ¡æ Ç÷´çº¯µ¿¼º °³¼±¿¡ ÃÖÀûÈ­ ÀÌ»óµ· ±âÀÚ 2023-02-06 17:40
Back to Top